Pharmacogenomics arrives

We've had the human genome sequence for a little while now, and it looks as though we're still some way off being able to exclude from most clinical trials those people who will probably suffer side effects.

Detalles Bibliográficos
Autor principal: Petsko, Gregory A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC463047/
https://www.ncbi.nlm.nih.gov/pubmed/15186481
http://dx.doi.org/10.1186/gb-2004-5-6-108
Descripción
Sumario:We've had the human genome sequence for a little while now, and it looks as though we're still some way off being able to exclude from most clinical trials those people who will probably suffer side effects.

Ejemplares similares